Publications by authors named "W Rein"

Claim this Profile
T
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial.
Jean-Christophe Corvol, Jean-Philippe Azulay, Björn Bosse, Yves Dauvilliers, Luc Defebvre, Werner Rein

Mov Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connexins as therapeutic targets in neurological and neuropsychiatric disorders.
M Charvériat, F Mouthon, W Rein, A Verkhratsky

Biochim Biophys Acta Mol Basis Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.
Fabien Sauvet, Mégane Erblang, Danielle Gomez-Merino, Arnaud Rabat, Mathias Guillard, Werner Rein

Br J Clin Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
Herbert Y Meltzer, Lisa Arvanitis, Deborah Bauer, Werner Rein,

Am J Psychiatry· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study.
Daniel Sechter, Joseph Peuskens, Odile Fleurot, Werner Rein, Yves Lecrubier

Neuropsychopharmacology· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis